On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations…

The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority…

CBP is enhancing Section 321 enforcement within ACE to ensure compliance with the $800 de minimis threshold. Starting June 26, the update will be deployed to the CERT environment. This enhancement will prevent the release of shipments claiming de minimis…

The Office of Foreign Assets Control issued a penalty notice for almost $216M on GVA Capital Ltd. They’re a venture capital firm in California. This is for violating the Russia sanctions and failing to comply with a subpoena. Read More

The United States Department of Justice declined to prosecute a private equity firm after they discovered criminal violations of export laws that one of their acquired companies had committed and disclosed them voluntarily. Read More

The United States Department of Justice unsealed an indictment against Iurii Gugnin, owner of cryptocurrency company Evita, for funneling > $500 million of payments through US banks / crypto exchanges while hiding the source and purpose of the transactions. Read…

In an IEEPA update, the Court of Appeals for the Federal Circuit granted the motion to continue collecting IEEPA fentanyl and reciprocal tariffs while the appeal is ongoing. They also said that since this is such an important case, they’re…